Actualités

Institut Imagine and SimforHealth announce a partnership in rare genetic diseases to support the training of healthcare professionals through digital simulation

13/10/2022

Portrait - Hélène Chautard, Director of Innovation and Technology Transfer at Imagine

01/06/2022

The Institut Imagine is the winner of the fifth wave of calls for university hospital research projects (RHU5) for the "COVIFERON" project

16/12/2021

Qarnot and the Imagine Institute start collaborations to optimize computing power and accelerate research against genetic diseases

18/10/2021

Launch of the Medtech Generator & Accelerator program developed by Institut du Cerveau, Institut Imagine and Institut de la Vision

10/09/2021

AtmosR, Medetia and Institut Imagine launch collaboration to develop a treatment for Ondine syndrome

03/06/2021

Portrait - Marc Chevalier, Head of Bioentrepreneurship

06/05/2021

A new treatment discovered at Institut Imagine and developed by QED Therapeutics enters clinical trial with a first child with achondroplasia in France

09/04/2021

COVID-19: Institut Imagine and Cerba HealthCare are partnering to test for patients likely to develop severe symptoms

18/03/2021

Medetia : towards a first treatment of severe ciliopathy in children

12/03/2021

Erminia Rubino, business developer at Institut Imagine

04/03/2021

Autoimmune and inflammatory diseases associated with primary immune deficiencies: 11 major healthcare players in France commit to accelerating the development of precision medicine

14/01/2021

Single cell analysis at the service of genetic diseases

13/10/2020

Partnership research - Imagine launches a website dedicated to industrialists

10/06/2020

ATRACTion: to change the situation in primary immunodeficiencies with autoimmunity or inflammation

17/07/2019